- Home
- SOL vs ME Comparison
SOL vs ME Comparison
Compare SOL & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- ME
- Stock Information
- Founded
- SOL 2005
- ME 2006
- Country
- SOL United States
- ME United States
- Employees
- SOL N/A
- ME N/A
- Industry
- SOL Semiconductors
- ME Precision Instruments
- Sector
- SOL Technology
- ME Health Care
- Exchange
- SOL Nasdaq
- ME Nasdaq
- Market Cap
- SOL 109.2M
- ME 113.9M
- IPO Year
- SOL 2008
- ME N/A
- Fundamental
- Price
- SOL $2.00
- ME $3.82
- Analyst Decision
- SOL Buy
- ME Hold
- Analyst Count
- SOL 3
- ME 1
- Target Price
- SOL $3.83
- ME $9.40
- AVG Volume (30 Days)
- SOL 218.5K
- ME 276.6K
- Earning Date
- SOL 11-14-2024
- ME 11-12-2024
- Dividend Yield
- SOL N/A
- ME N/A
- EPS Growth
- SOL N/A
- ME N/A
- EPS
- SOL N/A
- ME N/A
- Revenue
- SOL $103,577,000.00
- ME $193,260,000.00
- Revenue This Year
- SOL $44.70
- ME $21.93
- Revenue Next Year
- SOL $20.53
- ME $17.31
- P/E Ratio
- SOL N/A
- ME N/A
- Revenue Growth
- SOL 7.56
- ME N/A
- 52 Week Low
- SOL $1.41
- ME $3.80
- 52 Week High
- SOL $3.00
- ME $20.40
- Technical
- Relative Strength Index (RSI)
- SOL 34.81
- ME 27.01
- Support Level
- SOL $2.00
- ME $4.33
- Resistance Level
- SOL $2.18
- ME $5.35
- Average True Range (ATR)
- SOL 0.15
- ME 0.32
- MACD
- SOL -0.06
- ME -0.01
- Stochastic Oscillator
- SOL 0.00
- ME 1.29
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.